Protein Kinase A (PKA) is an important cellular signaling hub whose activity has long been 14 assumed to monotonically depend on the level of cyclic adenosine monophosphate (cAMP). 15
low and high cAMP doses. These transcriptional responses in turn influence the ability of MDCKI 23 cells to proliferate and form acini. Our data, supported by computational analyses, synthesize a 24 set of network interconnections involving PKA and other important signaling pathways into a 25 model that demonstrates how cells can capitalize on signal integration to create a diverse set of 26 responses to cAMP concentration and produce complex input-output relationships. 27 28 Introduction 29
Cyclic adenosine monophosphate (cAMP) is a secondary messenger that is an essential cellular 30 currency in all kingdoms of life (1) (2) (3) . In mammalian systems, cAMP is the major regulator of 31
Protein Kinase A (PKA), an important cellular kinase that exerts regulation on a wide spectrum of 32 cellular components, ranging from metabolic enzymes and cytoskeleton components to various 33 transcription factors, such as the cAMP response element binding protein (CREB)(4-7). PKA is a 34 holoenzyme composed of two regulatory subunits (PKAr) and two catalytic subunits (PKAc). Upon 35 binding of cAMP to the PKAr, all subunits dissociate, allowing PKAc to phosphorylate and regulate 36 its targets (8) . Through this influence on PKA, cAMP controls a large swath of crucial cellular 37 processes, such as proliferation, death and differentiation(3). 38
Because of its physiological importance, the level of cAMP is subject to intricate regulation on its 39 production by adenylyl cyclases (AC) and degradation by phosphodiesterases (PDE)(3). It has 40 been largely assumed that the activity of PKA correlates monotonically with the cAMP 41 concentration.. However, this simple view of the functional relationship between cAMP and 42
PKAhas recently been challenged. For example, it was demonstrated that the formation of 43 memory in rodents shows a biphasic pattern that depends on cAMP level(9). When the 44 hippocampus of mice was microinjected with low doses of cAMP analogs, they recalled their 45 learnt behavior better than control mice. However, when treated with high doses of cAMP analogs, 46 mice were worse at retaining the learnt behavior. A similar physiological biphasic relationship was 47 also noted between cAMP and the secretion rate of malpighi tubes of Drosophila(10). When these 48 organs were stimulated with low levels of cAMP, produced either with cAMP analogs or with an 49 optogenetically-controlled AC, they showed an increase in secretion rate. By contrast, when the 50 dose of cAMP was large, tubes had a secretion rate that was lower than unstimulated organs. 51
Furthermore, recent data have documented that serotonin (5-HT), a hormone known to increase 52 cAMP intracellular concentration (11), promotes the biphasic activation and inactivation of PKA in 53 mammary epithelial cells, and that these PKA patterns result in an increase and decrease of 54 transepithelial electrical resistance (TEER), respectively(12). Intriguingly, the same work also 55 demostrated that the stress related p38 MAPK (p38) is important for an overall inhibition of TEER, 56 therefore suggesting that p38 and perhaps other MAPKs are involved in the regulation of PKA in 57 a cAMP dependent fashion (12, 13) . These data give hints of a complex relationship between PKA 58 and cAMP in which multiple cellular pathways modulate the dependence of PKA on cAMP to 59 generate a biphasic relationship that induce distinct phenotypes at different cAMP concentrations. 60
To systematically study this relationship, we employed the bacterial light-activated 61 adenylyl cyclase bPAC (14) . bPAC was isolated from the Beggiatoa bacterial genus, and is 62 functional when expressed in other species such as yeast or mice (15, 16) , showing low activity in 63 the dark and rapid activation upon exposure to blue light to specifically elevate intracellular 64 cAMP (14) . 65
Unlike environmental and chemical inputs, bPAC specifically controls cAMP levels without 66 interference or crosstalk with other cellular variables. It therefore provided us with a convenient 67 tool to unambiguously probe the effects of cAMP dose on PKA activity and determine dose-68 dependent transcriptional response and physiological outcomes. We expressed bPAC in Madin-69
Darby Canine Kidney Type I (MDCKI) cells (17) where the cAMP-PKA pathway has been shown 70 to regulate acini formation(18). Many renal epithelial phenotypes, such as control of cyst size (19) , 71 podocyte differentiation(20), and fibrogenic programs in response to high glucose(21) are also 72 controlled by the cAMP-PKA pathway. Therefore, understanding the effects of increasing cAMP 73 concentrations in renal epithelial models, such as MDCK cells, is essential for understanding the 74 biology of normal tissues as well as the pathological tissues in diseases such as diabetic 75 glomerulopathy, nephrotic syndrome or polycystic kidney disease. 76
Our investigations using bPAC reveal that an increasing cAMP dose causally produces biphasic 77 activity of PKA --PKA activity increases and then decreases as a function of cAMP. ERK activity 78 exhibits the same biphasic behavior as a function of cAMP dose but in the opposite direction, 79 decreasing and then increasing as a function of cAMP. By contrast, p38 shows a monotonic 80 dependence on cAMP. We show that the PKA inhibition at high cAMP dose is not generated by 81 the known feedback loops regulating directly the level of cAMP, for example by regulation through 82 increased PDE activity. Instead, we uncover that PKA activity is the result of a network of 83 interactions involving cross-regulation with ERK and p38. We further demonstrate that the 84 different behaviors of PKA at low versus high cAMP dose have important phenotypic 85 consequences by eliciting two different cellular programs. We identify transcription factors that 86 bind genes upregulated in both programs, as well as program-specific transcription factors, such 87 as CREB that binds genes upregulated in low cAMP. Biological processes enriched in these two 88 programs suggest that different cAMP doses differentially regulate many important phenotypes, 89 such as proliferation and kidney morphogenesis. In particular, we show that concomitantly with 90 changes in gene expression, the program elicited by a high dose of cAMP triggers increased 91 proliferation and hampers the ability of the cell to form acini structures. 92
Together, these findings call for updating our understanding of PKA activity (at least in MDCK 93 cells, and potentially in other systems) as a faithful monotonically dependent reporter of cAMP 94 dose. Instead, we replace this notion with one in which PKA activity is finely tuned and modulated 95 by other cellular pathways. This modulation has large phenotypic consequences, eliciting 96 phenotypes reminiscent of involvement of these cells in health and disease of the kidney. 97
98

Results
99
PKA and ERK show a biphasic response to bPAC-generated cAMP inputs in MDCK cells 100
To examine the effects of increasing cAMP inputs in MDCK cells, we expressed bPAC (22), a 101 blue light responsive cyclase that we targeted to the cytoplasm (MDCKI + bPAC) ( Figure 1A ). To 102 test the ability of bPAC to rapidly produce cAMP in this cell line, we measured cAMP levels by 103 ELISA in the presence and absence of blue light. In the absence of light both MDCKI and 104 MDCKI+bPAC had similarly low levels of cAMP (~1E-1 nM/ng protein, Figure 1B ). After 20 105 minutes of continuous blue light exposure at maximum amplitude, only MDCKI+bPAC showed a 106 large increase in intracellular cAMP (1318nM/ng protein, Figure 1B ). To explore the range of 107 intracellular cAMP concentrations that can be generated using bPAC, we further exposed 108
MDCKI+bPAC cells to pulses of blue light of 30 second duration and varying duty cycles for 20 109 minutes. As expected, cAMP concentration increased with duty cycle ( Figure 1C ), reaching its 110 maximum at continuous blue light exposure, demonstrating that bPAC can be used to generate 111 a large range of precise cAMP levels spanning more than 3 orders of magnitude. 112 cAMP is a universal cellular messenger that acts upstream of PKA in all kingdoms of life (1). To 113 determine the repercussions of increasing cAMP levels on PKA activity, we exposed 114 MDCKI+bPAC cells to low (duty cycle = 1.7%) and high (duty cycle = 33%) bPAC inputs lasting 115 90 minutes and quantified PKA activity at different time points during light treatment by 116 immunoblotting with antibodies that recognize the phosphorylated PKA target motif or 117 phosphorylated cAMP Regulatory Element Binding Protein (CREB) ( Supplementary Figure 1) . 118
Parental MDCKI cells did not show any changes in PKA activity for this regimen of light exposure 119 (Supplementary Figure 1) . By contrast, PKA in MDCKI + bPAC cells was responsive to light 120 activation. Specifically, PKA activity increased in cells exposed to low cAMP, reaching its 121 maximum at 10 minutes (Supplementary Figure 1) and then declining to a new steady-state after 122 that. Remarkably, however, PKA activity decreased when cells were exposed to high cAMP 123 concentrations, with minimum activity reached at 5 minutes and maintained over the time course 124 (Supplementary Figure 1 ). To quantify cAMP regimes that lead to an increase versus a decrease 125 in PKA activity, we subjected MDCKI and MDCKI + bPAC cells to light inputs of different duty 126 cycles, ranging from 0 to continuous exposure and quantified their PKA activity at 20 minutes, a 127 time that was chosen because of the timescales of PKA activation and inactivation observed 128 above. We identified that PKA activity increases with cAMP concentration and reaches its peak 129 activity at ~1nM/mg protein (1.7% duty cycle). For cAMP concentrations above this value, PKA 130 activity decreases, reaching values that are lower than its basal value for cAMP concentrations 131 above 300nM/ng protein ( Figure 1D and E). PKA activity, therefore, exhibits a markedly biphasic 132 response to cAMP. 133 PKA activity is known to correlate negatively with mitogen activated kinase / extracellular signal-134 regulated kinase (ERK) pathway activity(23, 24). To further investigate the biphasic response 135 elicited by cAMP, we measured ERK1/2 phosphorylation levels in MDCKI and MDCKI + bPAC 136 cells subjected to the same light inputs as above. Remarkably, the ERK pathway showed a 137 biphasic response as a function of cAMP, but one that was the opposite of PKA. In this response, 138 doses of cAMP below 10nM/ng protein inhibited ERK1/2 below basal levels, with minimum activity 139 appearing again around 1nM/ng cAMP protein (1.7% light duty cycle, Figure 1D and E, 140
Supplementary Figure 1A ). Above 10nM/ng cAMP inputs, ERK activation rose above its basal 141 levels in the absence of stimulus. PKA has been implicated as a direct negative regulator of ERK 142 activity and we hypothesized that ERK inhibition at low cAMP levels is the result of PKA 143 activity(24). In agreement, when we treated cells subjected to no, low or high light inputs with H89 144 (a PKA inhibitor(25)), ERK activity increased above that of control cells (Supplementary Figure  145 2). Furthermore, the ERK activity of PKA-inhibited cells increased with duty cycle, suggesting that 146 the ERK is activated by cAMP. Therefore, the biphasic behavior of ERK seems to be at least 147 partially due to the competitive effects of direct activation by cAMP and inhibition by PKA. 148 149
Inhibition of PKA by high cAMP dose is independent of PDE activity and of the dissociation of 150
PKA holoenzyme 151
To better conceptualize the molecular modalities by which cAMP can exert its physiological 152 functions, we set to explore mechanisms of PKA regulation by cAMP and, in particular, of PKA 153 inhibition by a high dose of cAMP, leading to its biphasic activity as a function of cAMP levels. 154
Previous investigations have described inactivation of PKA by two mechanisms involving 155
feedback regulation that act primarily on cAMP. In the first mechanism, PKA activates PDEs that 156 degrade cAMP thereby reducing PKA activity(26). In the second mechanism, PKA promotes the 157 acidification of endosomes carrying AC-activating G protein-coupled receptors (GPCRs) (27) . 158
Since we were generating cAMP signals using an exogenous adenylyl cyclase, the second 159 mechanism was less relevant. We therefore set out to test if PDE activity is required for PKA 160 inhibition with high cAMP doses. We grew MDCKI + bPAC cells in the presence of DMSO or 161
Rolipram to inhibit PDE activity for 1h, exposed them to varying doses of light for 20min, and then 162 collected extracts from these cells and probed their PKA activity using immunoblotting 163 (Supplementary Figure 3 ). As expected, inhibition of PDEs with Rolipram changed the input-164 output relationship from cAMP to PKA. PKA activity increased in the absence of light, and with 165 cAMP inputs generated by duty cycles 0.3% and 1.7%, in cells exposed to Rolipram, when 166 compared to DMSO (Figure 2A ). Notably, however, for duty cycles larger than 1.7%, Rolipram 167 treatment lead to the sharp inhibition of PKA activity, suggesting that cells reached the threshold 168 of cAMP concentration required for PKA inhibition with a smaller input of light due to the lack of 169 cAMP degradation ( Figure 2A ). We therefore conclude that modulation of cAMP by PDE is not 170 likely to be a major contributor to the biphasic relationship between PKA activity and cAMP. 171
Next, we tested whether this biphasic response is generated by molecular interactions of the PKA 172 complex itself. One of the hallmarks of PKA activation by cAMP is the dissociation of its catalytic 173 subunits from the regulatory subunits that are bound to A-kinase anchoring proteins (AKAPs)(5). 174 PKA inhibition is also usually associated with the reassociation of the holoenzyme. We therefore 175 explored the state of the PKA holoenzyme under different regimes of cAMP input to determine 176 whether the association of the PKA subunits is preserved at high cAMP concentrations. In order 177 to visualize PKA localization in MDCKI cells, we expressed the catalytic subunit of human PKA 178 (PRKACA) fused to mRuby2. We quantified nuclear enrichment of PRKACA-mRuby2 as a proxy 179 for its dissociation from PKA regulatory units and AKAPs. We first quantified PRKACA-mRuby2 180 nuclear enrichment in cells exposed to Forskolin (adenylyl cyclase activator) or H89 (PKA 181 inhibitor). As expected, PKA activation by Forskolin lead to dissociation of PRKACA and 182 increased its nuclear localization in both MDCKI and MDCKI + bPAC cells ( Figure 2B ). Due to the 183 low basal activity of PKA, H89 treatment did not lead to a significant change in PRKACA 184 localization, which remained mostly in the cytoplasm. Next, we investigated how bPAC-generated 185 cAMP inputs changed the localization of PRKACA. To do so, we exposed MDCKI and MDCKI + 186 bPAC cells to 20min of light with duty cycle 1.7% (low cAMP) or 33% (high cAMP), which 187 increased or decreased PKA activity, respectively ( Figure 1E ). Light-induced low cAMP doses 188 increased the nuclear fraction of PRKACA in bPAC-expressing cells to levels similar to those 189 achieved by Forskolin treatment ( Figure 2B ). By contrast, the localization of PRKACA in the 190 parental cell line did not change in either light conditions ( Figure 2B ). In MDCKI + bPAC cells Earlier work has shown that several pathways, including the p38 MAPK pathway, are activated 201 by cAMP in both PKA-dependent and independent manner(28). Additionally, it has been shown 202 that p38 can inhibit the PKA-dependent increase in TEER of epithelial cells(12) leading us to 203 hypothesize that the p38 MAPK pathway might be directly activated by cAMP in MDCKI cells, and 204 that it might converge onto PKA with inhibitory action ( Figure 3A ). To explore this possibility, we 205 measured p38 phosphorylation in MDCKI and MDCKI + bPAC cells in response to increasing 206 cAMP inputs, using immunoblotting. Light exposure did not increase p38 phosphorylation in 207 parental MDCKI cells ( Figure 3B , C). By contrast, bPAC-expressing cells exposed to increasing 208 cAMP had a clear monotonic increase in phosphorylated p38 ( Figure 3B , C). 209
To test whether p38 exerts inhibitory influence on PKA, we treated MDCKI + bPAC cells with the 210 p38 inhibitor SB202190, exposed them to varying doses of light for 20min and measured PKA 211 Instead, the difference in PKA activity between DMSO and SB202190-treated cells was larger at 216 0 duty cycle, suggesting that p38 was active and was important for setting the basal activity of 217 PKA. This difference then decreased between duty cycles of 0 and 3.3% and increased again 218 with increasing duty cycles larger than 3.3% ( Figure 3E ). 219
While p38 inhibition changed the relationship between PKA and cAMP, therefore clearly 220 implicating p38 in regulation of PKA activity, it wasn't able to completely abolish the decline of 221 PKA activity at high cAMP levels. This implied that other inhibitory mechanisms are also at play. 222 ERK signaling, whose activity negatively correlates with PKA ( Figure 1E and F), is an obvious 223 candidate for such regulation ( Figure 3A ). To investigate the role of ERK, we treated MDCKI + 224 bPAC cells with U0216 (MEK inhibitor), then exposed cells to the same light doses as above and 225 measured PKA activity by immunoblotting ( Supplementary Figure 4) . Cells with and without MEK 226 inhibitor had the same relative PKA activity at light inputs below 3.3% duty cycle ( Figure 3D ), 227
indicating that ERK activity had little influence on PKA at low levels of cAMP. However, U0126 228 treated cells had a reduced PKA inhibition at larger light inputs, suggesting that ERK activity was 229 only effective in this regime. Taken together with the data demonstrating that ERK activity 230 decreased for low cAMP and increased again for high cAMP ( Figure 1F ), we suspected that the 231 most parsimonious model explaining the relationship between PKA and ERK is one in which they 232 counteract each other in a double negative interaction ( Figure 3A ). Intuitively, in this model, ERK 233 activity is a balance of activation by cAMP and inhibition by PKA. Low levels of cAMP cause large 234 PKA activity, whose inhibitory effect dominates causing ERK activity to decrease (Supplementary 235 Figure 2 ). At a certain threshold of cAMP though, the balance of power is flipped and ERK activity 236 starts increasing, therefore subjecting PKA to inhibition at high cAMP doses ( Figure 3E ). 237
This reasoning does not take into account other interactions such as those of p38. We next 238 explored whether the interactions between cAMP, PKA, ERK and p38, which were explored 239 pairwise above, are able to produce the molecular phenotypes in the various experiments when 240 considered together as an integrated system. To do so, we built a phenomenological 241 mathematical model that captures these interactions in the cAMP-PKA signaling network. The 242 input to this model is cAMP (different amounts produced by bPAC) and the output is PKA activity 243 (as a surrogate for the phosphorylation of its targets). In this model, cAMP activates PKA, p38 244 and ERK with different kinetics, and ERK and p38 inhibit PKA activity therefore mediating an 245 incoherent feedforward interaction from cAMP onto PKA ( Figure 3A , see methods and 246
Supplementary Information). To potentially account for the biphasic response of ERK and the 247 pattern of its inhibition data, the model also assumes that PKA inhibits ERK activation. These 248 interactions were modeled phenomenologically using enzymatic Hill functions in order to allow for 249 the possibility that the interactions are not direct, but instead can have multiple intermediate steps. 250
This functional form also allows for cooperativity and saturation in the substrate. In this form, the 251 model was easily able to reproduce all the data from bPAC as well as kinase inhibition 252 experiments. However, several structural features of the model, as well as choice of its 253 parameters were essential for this. 254
With regard to the topology of the model, the inhibition of ERK by PKA and the dependence of 255 both kinases on cAMP for their activation were vital for the biphasic behavior of ERK ( Figure 3H ) 256 as a function of cAMP in DMSO-treated cells. While ERK inhibition of PKA was not required by 257 the model to recapitulate the biphasic response of PKA to cAMP (as illustrated by the reduction 258 in PKA activity at high doses of light in the presence of U0126, Figure 3F ), this inhibition was 259 essential to induce a reduction in PKA activity in the absence of p38 activity ( Figure 3F ). In other 260 words, if ERK inhibition of PKA did not exist, PKA activity could never decrease when p38 is 261 inhibited because no negative influences on PKA would exist. Second, the monotonic rise in p38 262 activity with increasing duty cycles ( Figure 3I ) indicated that no inhibition of p38 by PKA was 263 needed, an insight further corroborated by the ability of the model to fully reproduce the data 264 without any feedback from p38 onto PKA ( Figure 3F ). However, a basal activity of p38 in the 265 absence of the cAMP input was required in order to reproduce the basal increase in PKA activity 266 upon inhibition of p38 by SB202190 ( Figure 3F and G) . 267
In terms of parameter constraints, to fully represent the phenotype of p38 inhibition, the model 268 required larger levels of cAMP in order to activate p38 and hence to trigger its negative effect on 269 PKA, giving PKA activity the opportunity to increase at low cAMP levels ( Figure 3F Supplemental Figure 5A and E). These parameters were necessary to reproduce the small effect 284 of ERK inhibition on PKA activity for small cAMP inputs ( Figure 3F and G) and its strong effect at 285 high cAMP inputs. Intuitively, at low cAMP concentrations, PKA inhibition of ERK dominates and 286 hence ERK plays a small role in modulating PKA activity ( Figure 3J and K). However, as cAMP 287 concentration increases and ERK passes a predicted sharp threshold where its activity starts 288 increasing again (representing an inflection point in the ERK activity, Figure 1E ), it starts exerting 289 a negative effect on PKA ( Figures 3J and K) . This is the regime where inhibition of ERK has a 290 notable effect as indicated by the data. 291 Finally, the model predicted that the inhibitory effect of p38 on PKA should increase noticeably 292 only after cAMP inputs larger than Kmp38 (duty cycle 6.7 and larger) and that it should reach 293 saturation for duty cycle 100% ( Figure 3L ). The saturation of this inhibitory effect was essential 294 for reproducing the quantitative pattern of PKA inhibition in the presence of U0126, where the rate 295 of inhibition of PKA seemed to decrease at high duty cycles (from 33% to 100%, Figure 3F and 296 G). Since in this experiment, only p38 is present as an inhibitory influence on PKA, and since its 297 level continues to increase at these high duty cycles, the fact that PKA activity assumes similar 298 values for different duty cycles while cAMP increases indicates that the influence of p38 on PKA 299 has to reach a saturation. This saturation effect should also be present in cells treated with 300 DMSO, which was absent in the experimental data (Figure 3Fand G), suggesting that additional 301
interactions between the MAPKs that become important at high cAMP levels might also be 302 present beyond the parsimonious model we have used. 303
Taken together, our data and computational modeling suggest that p38 activation modulates the 304 activity of PKA through a cAMP-driven incoherent feedforward loop that plays an important role 305 at all cAMP concentrations and that ERK engages in a double-negative feedback interaction 306 whose importance seems to manifest at higher cAMP concentration. These interactions are 307 integrated to produce a biphasic program of PKA activity for different cAMP concentrations. Given 308 that PKA is a master regulator of cell physiology, we next turned to investigating whether this 309 biphasic program has biological repercussions. 310 311 bPAC-generated cAMP inputs elicit differential transcriptional responses 312 PKA and ERK are known to target and modulate the activity of a wide array of transcription 313 factors(6, 7). We therefore postulated that the ability of bPAC-generated cAMP to induce their 314 biphasic response might have profound and distinct effects on the cellular transcriptome. To test 315 this hypothesis, we carried out mRNA sequencing of MDCKI and MDCKI+bPAC cells under no, 316 low, or high cAMP inputs (0%, 1.7% and 33% blue light duty cycle) for 2 hours. 317
In order to identify the effect of bPAC expression on cellular function in the absence of light, we 318 mined our dataset for genes that were differentially expressed in MDCKI + bPAC with no light 319 versus MDCKI parental cells (duty cycle = 0%). Additionally, we measured the effects of blue light 320 exposure on the MDCKI transcriptome by identifying genes that were differentially expressed in 321 MDCKI parental cells exposed to low or high light inputs (1.7% or 33%) versus no light input (0%). 322
We used DEseq2(29) to quantify Fold Change (FC) between conditions Using a threshold for fold 323 change in expression larger than 1.5 and an adjusted p-value smaller than 0.05 (|FC|>1.5, p<0.05, 324 see methods for justification of this choice), we identified 371 genes that were differentially 325 expressed due to bPAC expression and in the absence of light ( Supplementary Figure 6) .These 326 genes were enriched in Gene ontology(30) (GO) terms related to cellular adhesion and mitosis. 327
Reassuringly, these genes were not correlated with cAMP induced expression changes (see 328 below, Supplementary Figure 6 ). We also identified 434 genes that were differentially regulated 329 due to light exposure even in parental cell lines. These genes were removed from subsequent 330
analyses. 331
Our aim was to capture all genes that were differentially expressed in response to light-induced 332 cAMP inputs, and then classify them according to their patterns of cAMP dependence (monotonic 333 or biphasic dependence on cAMP). Using the same thresholds as above (|FC|>1.5, p<0.05), we 334 identified 3471 genes that are differentially expressed in response to one or both cAMP inputs, 335
as well as genes that are differentially expressed between cAMP doses ( Figure 4A , 336 Supplementary table 1). We used hierarchical clustering to group them according to their patterns. 337
We identified 8 clusters that were further combined in 4 qualitatively different classes. Genes in 338 clusters 1 and 2 were strongly repressed in low cAMP and weakly repressed or activated in high 339 cAMP, hence showing correlation with ERK activity. On the other hand, genes in clusters 3 and 340 4 were strongly activated in low cAMP and weakly activated or repressed in high cAMP dose, 341 therefore correlating with biphasic PKA activity. Finally, genes in clusters 5 and 6 were 342 monotonically activated by cAMP while genes in clusters 7 and 8 were monotonically repressed 343 by cAMP ( Figure 4A and B) . We confirmed the RNA sequencing results for four cAMP regulated 344 genes with qPCR experiments on independent RNA samples ( Supplementary Figure 7) . 345
To distill the various transcriptional programs corresponding to the different classes, we 346 performed Enrichr analysis(31) on genes from each class, focusing on transcription factors and 347 kinases that regulate these genes and GO enrichment analysis to identify biological processes in 348 which they are involved. Genes whose expression increased (clusters 5 and 6) or decreased 349 (clusters 7 and 8) monotonically with cAMP concentration showed enrichment for the binding of 350 specific transcription factors, such as NELFA or ELKF (Supplementary Figure 8) , and regulation 351 by kinases, such as SYK and AKT ( Supplementary Figure 8) . These genes were also enriched 352 for GO terms related to chromatin remodeling, protein kinase A signaling, regulation of epithelium 353 morphogenesis and DNA repair ( Supplementary Figure 9 ). While the promotors of the genes in 354 all clusters were enriched for the cAMP responsive element modulator (CREM) protein binding, 355 suggesting a common dependency on cAMP, we decided to focus our thorough analyses on the 356 clusters of genes that have a biphasic behavior, therefore reflecting the PKA or the ERK pattern, 357 in order to identify the distinct genetic programs encoded by low and high cAMP doses (clusters 358 1-2 and 3-4). We expected that genes whose expression correlate with ERK activity (clusters 1 359
and 2) could be controlled by transcriptional regulators that are activated by ERK, or by 360 transcriptional regulators that are inactivated in the absence of PKA activity. We found examples 361 that matched the two hypotheses. First, this set of genes was specifically enriched for Vitamin D 362
Receptor (VDR) and GA binding protein (GABP) binding (adjusted p-values 1.6x10 -14 and 1.0x10 -363 10 , Supplementary Figure 8) , which have been shown to have activity that is modulated by 364 ERK(32, 33). We also found enrichment for genes that are up-regulated upon CREB1 depletion 365 (adjusted p-value 2.2x10 -13 , Supplementary Figure 8 ), whose activity is PKA-dependent(34). 366
Interestingly, we also found that the set of genes whose expression correlates with ERK activity 367 (clusters 1 and 2) was enriched for genes that are upregulated in a protein kinase B (AKT1) 368 knockout and downregulated in the presence of an AKT1 active mutant (adjusted p-values 2.1x10 -369 5 and 1.8x10 -9 , Supplementary Figure 8) . These data suggest that AKT1 might also be 370 differentially regulated by cAMP dose and that its activity should correlate negatively with ERK 371 activity. To confirm these predictions, we measured phosphorylation level of AKT in parental 372 MDCKI and MDCKI + bPAC cells exposed to low or high cAMP inputs. While there were no 373 changes in AKT activity when the parental cell line was exposed to light, bPAC-carrying cells 374 increased phospho-AKT levels with low doses of cAMP and quenched them at high cAMP doses 375 ( Supplementary Figure 10) , again showing a biphasic response. 376
Next, we extended our analysis to the gene set whose expression correlated with PKA activity 377 (clusters 3 and 4), again hypothesizing that their pattern of expression either followed PKA activity 378 (they are activated by PKA-responsive transcription factors), or followed the absence of ERK 379 regulated activators (they are repressed by ERK-responsive transcriptional regulators). These 380 clusters were enriched in genes that are known targets of CREB1 and the histone demethylase 381 KDM5B (adjusted p-values 1.0x10 -14 and 1.3x10 -13 , Supplementary Figure 8) , an effect that is 382 likely mediated by PKA-driven regulation of chromatin remodelers and its activation of CREB1 383 transcription factor. In addition, we found a clear enrichment for genes that are known to be 384 upregulated following knockout of the transcription factor jun-B (JUNB, adjusted p-value 1.2x10-385 13 , Supplementary Figure 8 ), which is known to be activated by ERK as an immediate-early 386 gene(35). As a result, ERK is likely to exert a repressive effect on these genes, and their pattern 387 (e.g. activation at low cAMP) is therefore a result of differential alleviation of this repression as a 388 function of cAMP. 389
Finally, we performed GO enrichment analysis for the 2 gene classes ( Supplementary Figure 9) . 390
Genes belonging to clusters 1 and 2 (ERK correlated) were enriched in GO terms that 391 encompassed desmosome organization, stress activated MAPK cascade and positive regulation 392 of respiratory burst (Figure 4C, Supplementary Figure 9) . By contrast, genes in clusters 3 and 4 393 (PKA correlated) had strong enrichment for terms related to chromatin remodeling, kidney 394 morphogenesis and negative regulation of proliferation ( Figure 4D, Supplementary Figure 9) . 395
Together these findings suggest that the biphasic signaling responses of PKA and MAPK activity 396 in MDCKI cells to cAMP dose propagates to gene expression, therefore potentially programming 397 a large array of cellular phenotypes, ranging from proliferation, cell-cell and cell-extracellular 398 matrix interactions, metabolism, and kidney morphogenesis. 399 400
Cellular proliferation is positively influenced by high cAMP inputs 401
Many genes in clusters 3 and 4 were associated with negative control of cellular proliferation, and 402 these were repressed in the presence of high cAMP levels. This suggested that at a high cAMP 403 dose, repression of these genes positions MDCKI cells to a state similar to cells transiting to a 404 mesenchymal state(36) or in elongating regions of epithelial tubes, which have weaker cell-cell 405 interactions and higher rates of proliferation(37, 38). To test this possibility, we exposed parental 406 MDCKI and MDCKI + bPAC cells to no, low or high cAMP doses (duty cycle of 0, 1.7 and 33%) 407 for 2 hours and measured their mitotic fraction by histone H3S10 phosphorylation after 14h. As 408 expected, there were no significant changes in the mitotic fraction of MDCKI parental cells 409 exposed to light. Yet, MDCKI + bPAC cells stimulated with a high cAMP dose had a marked ~5-410 fold increase in their proliferation rate when compared to unstimulated cells ( Figure 5A ). Cells 411 exposed to the low cAMP input did not have a statistically significant change in the mitotic rate 412 (~1.5-fold reduction in comparison to cells exposed to 0% duty cycle) ( Figure 5A ), indicating that 413 only high cAMP treatment can significantly change the proliferation rate of MDCKI cells. These 414 data support the notion that different doses of the same secondary messenger (cAMP), which 415 result in different signaling and transcriptional patterns, can be decoded by cells to regulate 416 proliferation in a differential way. 417 418
Formation of MDCKI acini is differentially controlled by cAMP dose 419
We noted that kidney developmental genes and cell adhesion genes belonged to the class of 420 genes that correlate with PKA activity (clusters 3 and 4, Figure 4A and B). In addition, both PKA 421 and ERK signaling pathways have been shown to regulate different stages of kidney 422 development(19, 39, 39). Therefore, we predicted that different cAMP doses, through their 423 biphasic influence on PKA and ERK, might influence the formation and maintenance of kidney 424 structures differently. To examine this effect, we focused on acinar development of MDCKI cells. 425 MDCK acinus formation is a well-studied model of kidney epithelial structure and function(40, 41). 426
Correct formation and maintenance of MDCKI acini relies on the precise coordination of events 427 that incorporate cell interactions with basement membrane, cell polarization, formation of tight 428 junctions and dependence on an abundance of extracellular signals(18). 429
It is known that PKA activity and ERK inhibition is required for the rapid formation of acini(23). 430
Therefore, we hypothesized that low cAMP doses and accompanying high PKA activity leads to 431 the development of acini of normal size, while high doses of cAMP and associated ERK activation 432 lead to increased cellular mobility and concomitant incorrect acinar development. To test this 433 hypothesis, we quantified acinar size in MDCKI and MDCKI+bPAC cells grown in collagen gels 434 exposed to no, low or high cAMP inputs for 10 days. MDCKI cells exposed to all light conditions 435 showed no significant change in the area of their acini ( Figure 5B) , demonstrating that the effects 436 of light are negligible on acini formation and maintenance. By contrast, cAMP dose had a striking 437 effect on the area of bPAC-expressing acini ( Figure 5B ). Specifically, we identified that low and 438 high cAMP inputs had a significant effect on the distribution of acini area, in which the low dose 439 of cAMP increased the area of acini (median increase of 1.6-fold when compared to no cAMP), 440 and acini exposed to high doses of cAMP showed a reduction in their area (median reduction of 441 1.7-fold when compared to no cAMP) ( Figure 5B) . These data illustrate that tight control of 442 intracellular cAMP concentration and signaling activity is vital for the correct formation of 443 multicellular structures, and that MDCKI cells can use cAMP concentration and its paradoxical 444 effect on downstream pathways to generate an array of multicellular epithelial phenotypes. 445 446
Discussion 447
In this work, we used a combination of precise optogenetic stimulation to control cAMP levels in 448 living cells, with various cell biological readouts of its impact, to investigate the relationship 449 between cAMP dose and the PKA signaling pathway. We uncovered that PKA and ERK activity 450 is biphasic as a function of cAMP, with PKA activity increasing and then decreasing as a function 451 of cAMP and ERK activity showing the opposite behavior. To understand the repercussions of 452 these different dependencies, we used mRNA sequencing under two cAMP regimes (low and 453 high) to demonstrate that they indeed correspond to two different molecular programs and 454 physiological outcomes. Molecularly, we explored the intricate roles of p38 and the ERK 455 pathways in producing the biphasic PKA phenotype and presented a data-supported model in 456 which a poorly studied interaction between PKA and MAPKs inhibits PKA signaling pathway in a 457 cAMP-dependent way. As a result, PKA is under positive and negative influences from cAMP, 458 with the negative influence mediated by MAPKs. The interaction of these two modes of regulation, 459
and their relative strength, induces a non-monotonic dependence of PKA on cAMP in the MDCKI 460 cells we study here. 461
The biphasic response of PKA to cAMP has been previously observed in malpighi tubes of 462 flies(10), hypothalamus of mice(9), and human mammary cells(12) stimulated with small 463 molecules. However, the non-monotonic behaviors reported in most of these earlier works 464 resulted from chemical inputs that perturbed many cellular nodes, other than cAMP. Our use of 465 bPAC allowed us to circumvent this pleiotropy and uncouple feedback regulation on cAMP 466 production from PKA activity. As a result, we could unambiguously link PKA activity solely to the 467 Irrespective of the precise molecular mechanisms underlying cAMP effect on MAPKs and the 484 effect of MAPKs on PKA, the presence of at least two IFFL structures in the system is at the heart 485 of its biphasic behavior. An IFFL is a circuit motif that that is usually assumed to respond to a step 486 input with a transient response that then adapts close to its unstimulated state (46). However, a 487 less studied operational regime of IFFL is one in which they can give rise to dose-dependent 488 biphasic responses(47, 48), such as the ones shown here. We explored these regimes in the 489 context of the cAMP-PKA computational model and identified its specific parameter requirements. 490
It is interesting to think that in other cell types, or even in disease states, changes in parameter 491 values or network topology can give origin to radically different signaling responses out of the 492 same molecular players. For example, if PKA is unable to inhibit ERK, ERK activity would increase 493 monotonically with cAMP concentration. As a result, the signaling state of cells would be that of 494 active PKA and ERK, instead of active PKA and inhibited ERK, at low cAMP concentration. It is 495
far from clear what new functionalities or pathologies might ensue from these different signaling 496
states. This is particularly important in light of the fact that the capacity of cAMP to coordinate the 497 activity of important signaling pathways in MDCKI cells led to important changes in the expression 498 of many genes. Remarkably, several of those genes that were cAMP responsive followed either 499 a PKA or an ERK pattern, and correspondingly implemented two different programs. In the high 500 cAMP program (repressed PKA and activated ERK) the proliferation rate of cells was increased 501
and their ability to form acini reduced. By contrast, at a lower cAMP dose, proliferation rate was 502 smaller than at a high cAMP dose and the size of acini was larger, in accordance with the 503 previously described effects of PKA on acinar morphogenesis(23). Interestingly, in Polycystic 504
Kidney disease (PKD) cells, PKA is thought to activate MAPK and that activity of both pathways 505 is required for the measured increase in proliferation rate and acinus size(19). It is unclear if cells 506 are producing abnormal cAMP doses or if the decoding of cAMP dose is deficient. While therapies 507 for PKD have focused on reducing cAMP levels (49) , if the network topology present in MDCKI 508 cells is conserved in PKD cells, an alternative approach would be to increase cAMP, or directly 509 activate p38, to inhibit PKA activity and reduce cystogenesis. Finally, while the particular 510 interactions in the cAMP-PKA-MAPK network we uncover here might be specific to epithelial cells, 511 it is fascinating to think about how these links might be modulated, to shift the quantitative relationship between cAMP and PKA in different cell types. For example, a quantitative change 513 in the inhibition of PKA by p38 or ERK might shift where PKA activity reaches its peak as a function 514 of cAMP. A different change, balancing the timescale of the inhibiting and activating links on PKA, 515 might abolish the biphasic relationship altogether. One can also imagine that some cell types 516 might modulate these links dynamically, using inputs other than cAMP to impinge on the 517 relationship of p38 and ERK on PKA, weakening or strengthening it based on the particular 518 circumstances encoded in these inputs. 519 520
Methods and Materials 521
Cell culture 522 MDCKI cell line was a kind gift from Pavel Nedvestky. No mycoplasma contamination was 523 found. MDCKI + bPAC cells were generated by infecting MDCKI cells with pLenti-PGK-524 bPAC::NES (Addgene #130267). PKAc expressing cells were obtained by transfecting MDCKI 525 and MDCKI + bPAC cells with pPB-CAG-PRKACA::mRuby2 (Addgene #130268). Cells were 526 maintained in MEM (Gibco #11095072) supplemented with 10% Fetal Calf Serum (VWR 527 #89510-184) and 1X Anti-Anti (Gibco #15240062), and kept at 37 °C in a humidified incubator 528 with 5% CO2. 529 530
Antibodies and reagents 531
To probe signaling activity we used the following antibodies: anti-Phospho-PKA Substrate 532 16h, cells were exposed to no light or blue light (2.2 mW.cm -2 ) with different duty cycles for 551 20min. After light exposure cells were transferred to ice and cAMP concentration was 552 determined using the cAMP ELISA Kit (Cell biolabs #STA-501), following the manufacturer's 553 instructions. To determine protein concentration, ELISA samples were assayed using the Pierce 554 BCA Protein Assay Kit (Thermo Scientific Pierce #23227), following the manufacturer's 555 instructions. Measurements for cAMP ELISA and BCA Protein Assay kits were performed in a 556 Cells were then exposed to no light or blue light (2.2 mW.cm -2 ) with different duty cycles for 565 20min. Cells were lysed in cold M-PER (Thermo Scientific Pierce #PI78501) supplemented with 566 protease (Thermo Scientific Pierce #PIA32953) and phosphatase (Thermo Scientific Pierce #PI-567 88667) inhibitors for 20min. Proteins were separated in 7.5% Mini-PROTEAN® TGX™ Precast 568
Protein Gels (Biorad), probed with primary antibodies diluted in blocking buffer (Rockland 569
Immunochemical #MB-070) for 16h and with secondary antibodies diluted in blocking buffer for 570 2h. Proteins were detected by fluorescence in a Odyssey CLx (LI-COR). Phospho-PKA 571
Substrate quantification was performed for proteins above 75KDa. Tubulin was used as a 572 loading control. Quantification was done using ImageJ (NIH) and a custom Python Script 573 available on GitHub (https://github.com/jpfon/cAMP). 574 575 RNA library preparation and sequencing 576 1x10^6 cells were seeded in wells of 6-well plates (FALCON # 353046) in MEM without phenol 577 red (Gibco # 51200038) supplemented with 0.5% Fetal Calf Serum (VWR #89510-184). After 578 16h, cells were exposed to no light or blue light (2.2 mW.cm -2 ) with different duty cycles for 2h. 579
After light exposure cells were transferred to ice and total RNA was isolated using SPLIT RNA 580
Extraction Kit (Lexogen # 008.48), following the manufacturer's instructions. RNA quality was 581 assessed using RNA 6000 Nano chips (Agilent # 5067-1512) in a Bioanalyzer 2100 (Agilent). 582
RNA libraries for Illumina sequencing were prepared from 2ug of total RNA, using the QuantSeq 583 3' mRNA-Seq Library Prep Kit FWD for Illumina (Lexogen # 015.96). Library quality was 584 assessed using High Sensitivity DNA kit (Agilent # 5067-4626) in a Bioanalyzer 2100 (Agilent). 585
Sequencing was performed at the Center for Advanced Technology (UCSF), in a HiSeq 4000 586
(Illumina). One lane was used to generate 50bp single reads. Sequencing data is available GEO 587 (GSE134650) 588 589
RNA sequencing analysis 590
Low quality reads and reads containing adapters were removed from raw data. Gene counts 591
were generated using the standard workflow of Bluebee NGS Genomics Analysis Software 592 (QuantSeq-FWD) for the dog genome (https://platform.bluebee.com). Differentially expressed 593 (DE) genes were identified using the DESeq2 R package(29), with |logFC| >1.5 adjp >0.05, in 594 order to reduce the false discovery rate and genes whose expression change was small. 595
Clustering of DE genes was performed using a custom R script available on GitHub 596 (https://github.com/jpfon/cAMP). Gene Ontology term enrichment for genes in each cluster was 597 performed using DAVID(30) and displayed in a 2D scatterplot based on the semantic similarity 598 (Revigo(50)). Transcription factor and kinase regulation enrichment analysis was performed 599 using Enrichr (31). 600 601
Quantitative RT-PCR 602
Total RNA was prepared as described in the RNA library preparation section. First strand 603 synthesis was performed on 5ug of RNA using Superscript II (Invitrogen #18064-014) and 604 following the manufacturer's instructions. qPCR was performed in a CFX connect (Bio Rad), 605 using the PerfeCTa SYBR® Green FastMix (Quantabio #95072) and following the 606 Enrichr tool whose upregulated genes correlate to the genes included in the clusters identified in 838 
